2386-33-6 Usage
Uses
Used in Pharmaceutical Synthesis:
4-Acetyl-3,5-dimethyl-1H-pyrrole-2-carboxylic acid is utilized as a key intermediate in the synthesis of various pharmaceuticals. Its unique chemical properties and structural features make it a valuable component in the development of new drugs, contributing to the advancement of medicinal chemistry.
Used in Organic Compounds Synthesis:
4-ACETYL-3,5-DIMETHYL-1H-PYRROLE-2-CARBOXYLIC ACID also serves as a building block in the synthesis of a range of organic compounds, leveraging its reactivity and structural attributes to create diverse chemical entities for various applications.
Used in Dyes and Pigments Production:
Due to its reactive nature, 4-acetyl-3,5-dimethyl-1H-pyrrole-2-carboxylic acid is employed as a starting material in the production of dyes and pigments. Its versatile chemistry allows for the creation of a spectrum of colorants used across different industries.
Check Digit Verification of cas no
The CAS Registry Mumber 2386-33-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,3,8 and 6 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 2386-33:
(6*2)+(5*3)+(4*8)+(3*6)+(2*3)+(1*3)=86
86 % 10 = 6
So 2386-33-6 is a valid CAS Registry Number.
InChI:InChI=1/C9H11NO3/c1-4-7(6(3)11)5(2)10-8(4)9(12)13/h10H,1-3H3,(H,12,13)
2386-33-6Relevant academic research and scientific papers
PREPARATION OF 4,5-DIALKYL-3-ACYL-PYRROLE-2-CARBOXYLIC ACID DERIVATIVES BY FISCHER-FINK TYPE SYNTHESIS AND SUBSEQUENT ACYLATION
-
Page/Page column 24-26, (2008/06/13)
The present invention relates to an improved synthesis of pyrrole capping group precursors of formula I-a: comprising: combining an aqueous solution of the compound of formula IV-a: wherein R3 is C1-12 aliphatic, C3-12 alkyl-cycloaliphatic, C3-12 alkyl-aryl, C3-12 alkyl-heteroaryl, or C3-12 alkyl-cycloaliphatic; with a compound of formula V-a, wherein R1 and R2 are each independently C1-6 aliphatic; in the presence of zinc, water, and optionally an additional suitable solvent to form a compound of formula VI.
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
-
, (2008/06/13)
The present invention relates to compounds that inhibit serine protease activity, particularly the activity of hepatitis C virus NS3-NS4A protease. As such, they act by interfering with the life cycle of the hepatitis C virus and are also useful as antivi
